Literature DB >> 34581695

Metabolic Syndrome: Synergistic Risks for Doxorubicin-Induced Cardiotoxicity.

Elise P Gomez-Sanchez1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34581695      PMCID： PMC8665042          DOI： 10.1097/FJC.0000000000001140

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN： 0160-2446            Impact factor:   3.105


× No keyword cloud information.
  13 in total

Review 1.  11β-Hydroxysteroid dehydrogenase 1: Regeneration of active glucocorticoids is only part of the story.

Authors:  Alex Odermatt; Petra Klusonova
Journal:  J Steroid Biochem Mol Biol       Date:  2014-08-23       Impact factor: 4.292

2.  Pharmacokinetics and cardiotoxicity of doxorubicin and its secondary alcohol metabolite in rats.

Authors:  Xiaofang Zeng; Hongfu Cai; Jing Yang; Hongqiang Qiu; Yu Cheng; Maobai Liu
Journal:  Biomed Pharmacother       Date:  2019-05-15       Impact factor: 6.529

3.  Comparison of three definitions of metabolic syndrome and relation to risk of recurrent preeclampsia.

Authors:  Eva Stekkinger; Ralph R Scholten; Wieteke M Heidema; Marc E A Spaanderman
Journal:  Hypertens Pregnancy       Date:  2021-01-18       Impact factor: 2.108

4.  Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice.

Authors:  Georgy Hartmann; Vessela Vassileva; Micheline Piquette-Miller
Journal:  Drug Metab Dispos       Date:  2005-03-18       Impact factor: 3.922

5.  11β-Hydroxysteroid Dehydrogenase 1 Human Tissue Distribution, Selective Inhibitor, and Role in Doxorubicin Metabolism.

Authors:  Xin Yang; Wenyi Hua; Sangwoo Ryu; Phillip Yates; Cheng Chang; Hui Zhang; Li Di
Journal:  Drug Metab Dispos       Date:  2018-04-19       Impact factor: 3.922

6.  Influence of the pro-inflammatory cytokines on P-glycoprotein expression and functionality.

Authors:  Christine Fernandez; Marion Buyse; Michèle German-Fattal; François Gimenez
Journal:  J Pharm Pharm Sci       Date:  2004-11-17       Impact factor: 2.327

Review 7.  Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension.

Authors:  Felix J Frey; A Odermatt; Brigitte M Frey
Journal:  Curr Opin Nephrol Hypertens       Date:  2004-07       Impact factor: 2.894

Review 8.  11β-hydroxysteroid dehydrogenases: A growing multi-tasking family.

Authors:  Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2021-02-17       Impact factor: 4.102

9.  Cardiotoxic Effects of the Antineoplastic Doxorubicin in a Model of Metabolic Syndrome: Oxidative Stress and Transporter Expression in the Heart.

Authors:  Natalia Ogonowski; Natalia Lucía Rukavina Mikusic; Nicolás Martín Kouyoumdzian; Marcelo Roberto Choi; Andrea Fellet; Ana María Balaszczuk; Stella Maris Celuch
Journal:  J Cardiovasc Pharmacol       Date:  2021-12-01       Impact factor: 3.105

10.  Chronic inflammation up-regulates P-gp in peripheral mononuclear blood cells via the STAT3/Nf-κb pathway in 2,4,6-trinitrobenzene sulfonic acid-induced colitis mice.

Authors:  Jiali Liu; Fang Zhou; Qianying Chen; An Kang; Meng Lu; Wenyue Liu; Xiaojie Zang; Guangji Wang; Jingwei Zhang
Journal:  Sci Rep       Date:  2015-09-01       Impact factor: 4.379
View more
  1 in total

Review 1.  Novel Mechanisms of Anthracycline-Induced Cardiovascular Toxicity: A Focus on Thrombosis, Cardiac Atrophy, and Programmed Cell Death.

Authors:  Silvio Antoniak; Sukanya Phungphong; Zhaokang Cheng; Brian C Jensen
Journal:  Front Cardiovasc Med       Date:  2022-01-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.